Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi‐specific monoclonal antibody MsMab‐1

Xing Liu(Capital Medical University), Michiaki Takagi(Yamagata University), Yasushi Naganuma(Yamagata University), Mika K. Kaneko(Tohoku University), Yukinari Kato(Tohoku University), Satoshi Ogasawara(Kyoto University), Yuta Tsujimoto(Tohoku University), Takashi Tsuchiya(Yamagata University), Masato Sugawara(Yamagata University), Mitsunori Yamakawa(Yamagata University)
Cancer Medicine
October 17, 2013
Cited by 52


Related Papers